Skip Navigation


Rheumatology Advance Access originally published online on February 3, 2004
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
43/4/408    most recent
keh129v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (8)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Birrell, F. N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Birrell, F. N.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Rheumatology 2004; 43: 408-409
Rheumatology Vol. 43 No. 4 (c) British Society for Rheumatology 2004; all rights reserved

Editorial

Patterns of joint pain: lessons from epidemiology

F. N. Birrell1,2,3

1Rheumatology, University of Newcastle upon Tyne, Newcastle upon Tyne, UK, 2Rheumatology, Wansbeck General Hospital, Ashington, UK and 3Musculoskeletal Unit, Freeman Hospital, Newcastle upon Tyne, UK

Correspondence to: F. N. Birrell, Rheumatology, 4th Floor, Cookson Building, Framlington Place, University of Newcastle upon Tyne, Newcastle upon Tyne NE2 4HH, UK. E-mail: fraser.birrell@ncl.ac.uk

The first 10% of the full text of this article appears below.

Osteoarthritis (OA) is important to healthcare providers because it is common, disabling, and expensive to the individual and to society [1]. However, historically OA has not been a priority area either for the clinician or the researcher, compared with inflammatory arthritides, including rheumatoid arthritis (RA) [2]. The busy clinician may prefer to see patients for whom proven therapies, preferably capable of modifying the disease process, are available; the researcher is guided by the directions funding bodies identify as priorities.

However, the perception of OA is shifting. Clinicians are beginning to appreciate that there is a growing evidence base for non-pharmacological interventions, including orthoses [3], exercise [4] and those with potential for disease modification, such as glucosamine sulphate [5]. Research groups are also appreciating the strategic importance . . . [Full Text of this Article]


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Rheumatology (Oxford)Home page
E. Thomas, P. R. Croft, and K. S. Dziedzic
Hand problems in community-dwelling older adults: onset and effect on global physical function over a 3-year period
Rheumatology, February 1, 2009; 48(2): 183 - 187.
[Abstract] [Full Text] [PDF]

Home page
 Rheumatology (Oxford)Home page
D. McGonagle, A. L. Tan, A. J. Grainger, and M. Benjamin
Heberden's nodes and what Heberden could not see: the pivotal role of ligaments in the pathogenesis of early nodal osteoarthritis and beyond
Rheumatology, September 1, 2008; 47(9): 1278 - 1285.
[Abstract] [Full Text] [PDF]

Home page
 Rheumatology (Oxford)Home page
F. Birrell, N. K. Arden, P. G. Conaghan, C. Cooper, P. Dieppe, and M. Doherty
Is it time for more rheumatologists to embrace osteoarthritis?
Rheumatology, July 1, 2005; 44(7): 829 - 830.
[Full Text] [PDF]